5,884
Views
12
CrossRef citations to date
0
Altmetric
Review

A systematic literature review to assess the burden of herpes zoster disease in China

, ORCID Icon, , ORCID Icon, , , , ORCID Icon, , , , & show all
Pages 165-179 | Received 20 Apr 2020, Accepted 02 Jul 2020, Published online: 30 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Zhujiazi Zhang, Xinnong Liu, Luodan Suo, Dan Zhao, Jingbin Pan & Li Lu. (2023) The incidence of herpes zoster in China: A meta-analysis and evidence quality assessment. Human Vaccines & Immunotherapeutics 19:2.
Read now
Xinyue Lu, Jia Lu, Felicia Zhang, Abram L. Wagner, Liping Zhang, Kewen Mei, Baichu Guan & Yihan Lu. (2021) Low willingness to vaccinate against herpes zoster in a Chinese metropolis. Human Vaccines & Immunotherapeutics 17:11, pages 4163-4170.
Read now
Christa Lee, Ning Jiang, Haiwen Tang, Chiyu Ye, Yanfei Yuan & Desmond Curran. (2021) Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing. Human Vaccines & Immunotherapeutics 17:10, pages 3735-3746.
Read now

Articles from other publishers (9)

Ming Wang, Mingzheng Hu, Yanshang Wang, Chao Long, Yiqi Xia, Dawei Zhu, Weiying Zhao, Beibei Yuan & Ping He. (2023) Willingness to vaccinate against herpes zoster in Chinese urban population: a mixed-methods study. BMJ Open 13:12, pages e079115.
Crossref
Minghuan Jiang, Xuelin Yao, Jin Peng, Liuxin Feng, Yue Ma, Xinke Shi, Yu Fang & Hai Fang. (2023) Cost-Effectiveness of Recombinant Zoster Vaccine for Adults Aged ≥50 Years in China. American Journal of Preventive Medicine 65:5, pages 818-826.
Crossref
Christa Lee, Nikolaos Giannelos, Desmond Curran, Hengjin Dong, Haiwen Tang, Ning Jiang, Chiyu Ye, Yanfei Yuan & Cheryl Ng. (2023) Lifetime risk of herpes zoster in the population of Beijing, China. Public Health in Practice 5, pages 100356.
Crossref
Binshan Jiang, Qing Wang, Zhenzhong Wang, Yunshao Xu, Tao Yang, Weizhong Yang, Mengmeng Jia & Luzhao Feng. (2022) Willingness to accept herpes zoster vaccines and the influencing factors in China. BMC Infectious Diseases 22:1.
Crossref
Dan Yu, Ying Liu, Mu-Tong Zhao, Kai-Hu Yao, Mao-Quan Qin & Lin Ma. (2022) Clinical characteristics of herpes zoster in a pediatric hospital in China from 2007 to 2020. World Journal of Pediatrics 18:8, pages 574-578.
Crossref
Qinghong Meng, Bingsong Wang, Xianlai Zhang, Zhen Li, Wenjie Wang & Kaihu Yao. (2022) Case Report: Various Clinical Manifestations Caused by Varicella-Zoster Virus in a Family. Frontiers in Pediatrics 10.
Crossref
Zhen-Wei Li, Chao-Nan Yin, Hai-Tao Wang, Wan-Yu Du, Wen-Jing Wang, Fu-Zhong Xue, Lin Zhao & Wu-Chun Cao. (2022) Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013–2017: Findings from a population-based observational study. Vaccine: X 10, pages 100145.
Crossref
Catherina X. Pan, Michelle S. Lee & Vinod E. Nambudiri. (2022) Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Therapeutic Advances in Vaccines and Immunotherapy 10, pages 251513552210845.
Crossref
Zhouhong Fan, Xin Zheng, Dongbai Li, Haopeng Chen & Lingchao Li. (2022) Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia. Medicine 101:23, pages e29394.
Crossref